SPECIFICS OF MYOCARDIAL REMODELING IN PATIENTS WITH ATRIAL FIBRILLATION AND ASSOCIATED ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS

Authors

  • M. V. Hrebenyk I. Horbachevsky Ternopil National Medical University
  • Yu. V. Honcharuk I. Horbachevsky Ternopil National Medical University

DOI:

https://doi.org/10.11603/1811-2471.2022.v.i1.12822

Keywords:

remodeling, atrial fibrillation, arterial hypertension, diabetes

Abstract

SUMMARY. In modern publications the term "Hypertensive heart disease" is traced. It is regarded as a set of changes in the LV, LA and coronary arteries due to chronic hypertension. The development of AF in LVH is realized through certain triggers that are possible in the formation of HHD. The formation of re-entry sites around fibrosis zones in the hypertrophied part of the myocardium contributes to the occurrence of AF in patients with HHD. Therefore, AF should be considered as one of the manifestations of HHD.

The aim –  to determine the effect of myocardial remodeling type on the occurrence and persistence of AF in hypertension and type 2 DM in the context of HHD.

Material and Methods. 214 patients with AF, hypertension and DM were examined. Men – 56.5 %, woman – 43.5 %. Among patients with AF, 34.3 % showed paroxysmal, 46.4 % persistent and 19.3  % permanent.

Results. HHD was detected in 67.2  % of patients with hypertension. At HHD the anamnesis of hypertension made (14,37±0,76) years, whereas at persons without it – (7,92±0,47) years (p=0,01). Age (p=0.002) and concentric LV remodeling (p=0.004) were the most significant predictors of the first episode of AF. The relationship between the increase in RWT in our patients with an increase in the duration of hypertension and SBP (p=0.0001).

The formation of a concentric type of LVH with concomitant hypertension and DM was associated with the development of AF. The main risk factors for AF in patients with hypertension were LV hypertrophy, LA dilatation, concentric form of LV remodeling and obesity. The development of eccentric hypertrophy was influenced only by AF, and most often its constant form. (p = 0.05) It is proved that concentric hypertrophy is more common in women and in DM, while in obesity - eccentric.

Conclusion. Thus, HHD develops with a duration of hypertension of about 14 years. The development of the first episode of AF was influenced by age and concentric hypertrophy. RWT increased with longer duration of hypertension and increasing the level of SBP. The development of eccentric hypertrophy was facilitated by AF, and most often its constant form. Concentric hypertrophy develops in DM, in obesity - eccentric.

References

Eremenko, E.Yu., Egorova, E.A., & Sokolova, L.A. (2011). Hypertonycheskoe remodelyrovanye myokarda kak faktor ryska razvytyia fybrylliatsyy predserdyi u patsyentov s arteryalnoi hypertenzyei [Hypertensive myocardial remodeling as a risk factor for atrial fibrillation in patients with hypertension]. Vestnik aritmologii – Journal of Arrhythmology, 64, 38-43. Retrieved from: https://vestar.elpub.ru [in Russian].

Barsukov, A.V., Sveklyna, T.S., Talanceva, M.S., & Shustov, S.B. (2011). Arteryalnaia hypertenzyia, sakharnui dyabet 2 typa y fybrylliatsyia predserdyi kak samostoiatelnaia medytsynskaia problema [Arterial hypertension, type 2 diabetes mellitus and atrial fibrillation as an independent medical problem]. Arterialnaya gipertenziya – Hipertensión Arterial, 17(2), 108-114. Retrieved from: https://htn.almazovcentre.ru/jour/article/view/1597 [in Russian].

Koval, S.M., Sniggurska, IO., Bozhko, V.V. & Myloslavskyi, D.K. (2020). Problema rehresuvannia hipertonichnoi khvoroby sertsia u khvorykh na arterialnu hipertenziiu [The problem of regression of hypertension in patients with hypertension]. Arterialnaya gipertenziya – Arterial Hypertension, 13(6), 28-34. Retrieved from: https://doi.org/10.22141/2224-1485.13.6.2020.223078 [in Ukrainian].

Tackling, G., & Borhade, M.B. (2021). Hypertensive Heart Disease. Treasure Island (FL): StatPearls Publishing. Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK539800/.

Feger, J. Hypertensive heart disease. Reference article, Radiopaedia.org. Retrieved from: https://doi.org/ 10.53347/rID-84874.

Dzyak, G.V., Vasylenko, A.M., & Potabashnyi, V.A. (2015). Pochemu terapevty i kardiologi etu mezhdunarodnuyu traktovku porazheniya serdtsa u bolnykh s arterialnoy gipertenziyey svodyat tolko k trem bukvam – GLZH? [Why do therapists and cardiologists reduce this international interpretation of heart damage in patients with arterial hypertension to only three letters – LVH?]. Healthy Ukraine. Cardiology, Rheumatology, Cardiosurgery, 4(41), 18-20. Retrieved from: http://health-ua.com/multimedia/2/1/3/4/8/1514979799.pdf [in Russian].

Seko, Y., Kato, T., Haruna, T., Izumi, T., Miyamoto, S., & Nakane, E., (2018). Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling. Sci Rep, 8(1), 6366. Retrieved from: https://doi.org/10.1038/s41598-018-24875-1.

Bazylev, V.V., Karpukhin, V.G., Mykulyak, A.Y., & Palkova, V.A. (2017). Fibroznyye izmeneniya miokarda kak nezavisimyy prediktor narusheniya ritma u patsiyentov s gipertroficheskoy kardiomiopatiyey [Myocardial fibrotic changes as an independent predictor of arrhythmia in patients with hypertrophic cardiomyopathy]. Meditsinskaya vizualizatsiya – Medical Visualization, 21(6), 19-24. Retrieved from: https://core.ac.uk/download/229933477.pdf [in Russian].

Karetnikova, V.N., Kashtalap, V.V., Kosareva, S.N., & Barbarash, O.L. (2017). Fibroz miokarda: sovremennyye aspekty problemy [Myocardial fibrosis: Current aspects of the problem]. Terapevticheskiy arkhiv – Therapeutic Archive, 89(1), 88-93. Retrieved from: https://doi.org/10.17116/terarkh201789188-93 [in Russian].

Proietti, M., Marra, A. M., Tassone, E. J., De Vuono, S., Corrao, S., & Gobbi, P. (2015). Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation. The American Journal of Cardiology, 116(6), 877-882. Retrieved from: https://doi.org/10.1016/j.amjcard.2015.05.060.

Szymanski, F.M., Filipiak, K.J., Platek, A.E., Kotkowski, M., & Opolski, G. (2015). Prevalence of arterial hypertension in patients with atrial fibrillation undergoing ablation – a prospective, cohort study. Journal of Hypertension, 33, 65. Retrieved from https://journals.viamedica.pl/arterial_hypertension/article/view/43463.

Koroliuk, O. (2018). Hipertrofiia livoho shlunochka pry arterialnii hipertenzii: suchasni uiavlennia ta diahnostychno-likuvalnyi pidkhid. [Left ventricular hypertrophy in hypertension: modern ideas and diagnostic and therapeutic approach]. Medychna hazeta «Zdorovia Ukrainy 21 storichchia» – Medical Newspaper "Health of Ukraine 21st Century", 23(444), 21-23. Retrieved from: http://health-ua.com/article/40910-gpertrofya-lvogo-shlunochka-pri-arteralnj-gpertenz-suchasn-uyavlennya-ta-da [in Ukrainian].

Published

2022-06-08

How to Cite

Hrebenyk, M. V., & Honcharuk, Y. V. (2022). SPECIFICS OF MYOCARDIAL REMODELING IN PATIENTS WITH ATRIAL FIBRILLATION AND ASSOCIATED ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS. Achievements of Clinical and Experimental Medicine, (1), 75–80. https://doi.org/10.11603/1811-2471.2022.v.i1.12822

Issue

Section

Оригінальні дослідження